New tetanus shot shows promise in early trial
NCT ID NCT05625477
First seen Sep 30, 2025 · Last updated May 23, 2026 · Updated 30 times
Summary
This study tested a new injection called TNM002 in 240 healthy Chinese adults to see if it can protect against tetanus. Participants received either TNM002, the standard tetanus shot, or a placebo. The main goal was to measure if TNM002 raises antibody levels enough to prevent tetanus. Results will help decide if further testing is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TETANUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
PKUCare Luzhong Hospital
Zibo, Shandong, China
-
The First Affiliated Hospital of Shantou University Medical College
Shantou, Guangdong, China
-
Wuxi People's Hospital
Wuxi, Jiangsu, China
-
Yunnan Provincial Hospital of Traditional Chinese Medicine
Kunming, Yunnan, China
Conditions
Explore the condition pages connected to this study.